NEOGENOMICS INC — Director's Dealing 2014

Aug 11, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NEOGENOMICS INC (NEO)
CIK: 0001077183
Period of Report: 2014-04-15

Reporting Person: DENT MICHAEL T (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-04-15	Common Stock	A	3000	$3.05	Acquired	3000	Direct
2014-07-25	Common Stock	A	400000	$0.25	Acquired	400000	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-07-25	Stock Option (Right to buy)	$0.25	C	400000	Acquired	2014-08-04	Common Stock (400000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	1528050	Indirect
Common Stock	34500	Direct

Footnotes

F1: On April 15, 2014 the Board of Directors approved and granted a restricted stock award of 3,000 shares of NeoGenomics common stock. The terms of the award call for 750 shares to vest on the last day of the next 4 quarters starting on June 30, 2014 as long as Dr. Dent remains a Director of the Company.

F2: On July 25, 2014 Dr. Dent exercised 400,000 options and recieved 400,000 shares.